The preferential injury of outer renal medulla after ischemia-reperfusion relies on high oxidative metabolism

Grégoire Arnoux,Justine Serre,Thomas Verissimo,Matthieu Tihy,Sandrine Placier,Charles Verney,Frédéric Sangla,Deborah Paolucci,Marylise Fernandez,Sophie de Seigneux,Sebastian Sgardello,Maarten Naesens,Juliette Hadchouel,Éric Feraille,Stellor Nlandu Khodo,Pierre Galichon,David Legouis

DOI: https://doi.org/10.1101/2024.09.12.612245

2024-09-14

Abstract:Acute kidney injury (AKI) is a prevalent and significant complication in critically ill patients, and its management remains a considerable challenge. The kidney is a highly metabolic organ, consuming and producing substantial amounts of ATP, mainly through mitochondrial oxidative phosphorylation. Recently, mitochondrial dysfunction has been identified as a key factor in the pathophysiology of AKI and the progression to chronic kidney disease. The kidney is a complex organ, comprising millions of structural and functional units. These nephrons are composed of different cell types dwelling within specific metabolic microenvironment. Whether the metabolic spatialization in the kidney has consequences on tubular injury distribution and severity remains unclear. In this study, we identified the high metabolic rate of the outer stripe of the outer medulla (OSOM) and its substrate preference flexibility, relying on both glycolysis and fatty acid oxidation (FAO) to fulfill its ATP demands. We demonstrated that the OSOM is susceptible to mitochondrial and FAO impairment induced by propofol, the most used sedative in intensive care settings, which exacerbates tubular injury during AKI. In the clinical setting, the cumulative dose of propofol is positively correlated with oxidative metabolism disruption and histological and function outcomes in renal allograft recipients. Finally, we found that the loop of Henle, the OSOM major constituent, was the most injured segment during AKI in patients. This study shows how renal metabolic spatialization impacts tubular injury severity. We identified the OSOM as the most metabolically active and the most injured region of the kidney both in humans and mice. We demonstrated that propofol is a potent inhibitor of renal mitochondrial function and FAO exacerbating tubular injury in the OSOM upon IRI.

Physiology

What problem does this paper attempt to address?

This paper attempts to address the issues of the distribution and severity of renal tubular injury in acute kidney injury (AKI), especially to explore the impact of renal metabolic spatialization on renal tubular injury. Specifically, the researchers focused on the outer stripe of the outer medulla (OSOM) area, as it is the most metabolically active and most vulnerable area in the kidney. Through a variety of experimental methods, including spatial transcriptomics, Seahorse experiments, ex - vivo kidney perfusion experiments, and analysis of clinical data, the study revealed the metabolic characteristics of the OSOM area in AKI and its sensitivity to renal tubular injury. In addition, the study also explored the aggravating effect of the anesthetic propofol on renal tubular injury, especially its impact in ischemia - reperfusion injury (IRI).

### Main questions:
1. **Is the distribution and severity of renal tubular injury related to the spatialization of renal metabolism?**
- The study found that OSOM is the most metabolically active area in the kidney and also the most severely damaged area in AKI.

2. **How does propofol affect renal metabolic function and renal tubular injury?**
- Propofol was found to inhibit renal mitochondrial function and fatty acid oxidation (FAO), thereby exacerbating renal tubular injury caused by IRI.

### Key findings:
- **High metabolic rate of OSOM**: The OSOM area has a high metabolic rate and depends on glycolysis and fatty acid oxidation (FAO) to meet its ATP requirements.
- **Negative impact of propofol**: Propofol can significantly inhibit renal mitochondrial function and FAO, leading to exacerbated renal tubular injury during AKI.
- **Clinical relevance**: Clinical data show that the cumulative dose of propofol is positively correlated with oxidative metabolic disorders and the deterioration of histological and functional outcomes in renal transplant recipients.

Through these studies, the paper provides new insights into the pathogenesis of AKI and provides theoretical support for reducing the negative impact of propofol on renal function in clinical practice.